申请人:SRI International
公开号:US04518609A1
公开(公告)日:1985-05-21
Naphthenic and heterocyclic retinoic acid analogues such as (E)-6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthaldehyde, methyl 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoate, 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoic acid, (E)-1-(5-carbethoxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, (E)-1-(5-carboxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene, (E)-1-(5-carbethoxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, and (E)-1-(5-carboxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene. These retinoids are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.
萘环和杂环类视黄酸类似物,如(E)-6-[2-(2,6,6-三甲基-1-环己烯-1-基)乙烯基]-2-萘醛,甲基6-[2-(2,6,6-三甲基-1-环己烯-1-基)乙烯基]-2-萘酸甲酯,6-[2-(2,6,6-三甲基-1-环己烯-1-基)乙烯基]-2-萘甲酸,(E)-1-(5-羧乙氧基-2-呋喃基)-2-甲基-4-(2,6,6-三甲基-1-环己烯-1-基)-1,3-丁二烯,(E)-1-(5-羧基-2-呋喃基)-2-甲基-4-(2,6,6-三甲基-1-环己烯-1-基)-1,3-丁二烯,(E)-1-(5-羧乙氧基噻吩-2-基)-2-甲基-4-(2,6,6-三甲基-1-环己烯-1-基)-1,3-丁二烯和(E)-1-(5-羧基噻吩-2-基)-2-甲基-4-(2,6,6-三甲基-1-环己烯-1-基)-1,3-丁二烯。这些视黄酸衍生物可用作化学预防剂,用于抑制上皮细胞中的肿瘤促进和治疗非恶性皮肤疾病。